• News
  • SAN DIEGO
  • BioTech

DexCom cited as bellwether

CNBC stock commentator Jim Cramer on Friday cited San Diego’s DexCom Inc. (Nasdaq: DXCM) as a bellwether for the stock market, which should go into a turnaround on Wall Street within the next year.

To continue reading, subscribe now
or
log in to your account
User Response
0 UserComments

Dexcom Inc.

Company Website

5555 Oberlin Drive
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
DXCM
44.08
  1.24  
+ 2.89%
496,559,000
49.83
27.10

Insider Trade Data

Date Insider Shares Type Value
10/20/2014 Roper, Jess 8,000 Sell $329,463
10/20/2014 Roper, Jess 8,000 Exchange $61,040
10/15/2014 Gregg, Terrance H 35,000 Sell $1,386,970
10/15/2014 Gregg, Terrance H 25,000 Exchange $171,250
10/13/2014 Balo, Andrew K 10,000 Sell $404,165

Dexcom Inc. Executive(s):

Terrance Gregg

  • Chief Executive Officer, Director

Kevin Sayer

  • Director, President

Patrick Murphy

  • Assist. General Counsel

Similar Companies

NAICS - -
Subscribe Today!